Product
Zilebesiran
Aliases
ALN-AGT01
3 clinical trials
2 indications
Indication
HypertensionIndication
High Cardiovascular RiskClinical trial
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Zilebesiran Used as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive MedicationStatus: Active (not recruiting), Estimated PCD: 2023-09-18
Clinical trial
A Phase 1/2, Randomized, Double-blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacodynamics, and Pharmacokinetics of Zilebesiran in Japanese Patients With Mild to Moderate HypertensionStatus: Not yet recruiting, Estimated PCD: 2025-09-30
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Zilebesiran Used as Add-on Therapy in Adult Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive MedicationsStatus: Recruiting, Estimated PCD: 2025-03-20